# Top 50 Biotechnology Startup Investors in China in May 2026

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 36
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

## Sequoia Capital China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 34
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Artificial Intelligence

We help founders build enduring companies.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 24
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Kaitai Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 20
- Stages: Series A, Angel, Seed
- Focus: Biotechnology, Health Care, Pharmaceutical

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

## IDG Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Software, Internet, E-Commerce

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

## Sherpa Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

## Hillhouse Capital Group
- Type: VC Fund
- Location: Changyang, Beijing, China
- Relevant deals: 17
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Software

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 16
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Northern Light Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Internet

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## Frees Fund
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Seed, Angel
- Focus: Artificial Intelligence, E-Commerce, Health Care

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

## TF Capital
- Type: VC Fund
- Location: Pudong, Shandong, China
- Relevant deals: 14
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Pharmaceutical

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 13
- Stages: Series A, Series B, Series C
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 13
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

## CDH Investments
- Type: VC Fund
- Location: Kowloon City, Kowloon, Hong Kong
- Relevant deals: 11
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Biotechnology, Health Care

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

## Addor Capital
- Type: VC Fund
- Location: Nanjing, Jiangsu, China
- Relevant deals: 10
- Stages: Series A, Series B
- Focus: Manufacturing, Medical, Electronics

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

## Puhua Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 10
- Stages: Series A, Series B, Angel
- Focus: Health Care, Medical, Biotechnology

Puhua Capital is an equity investment firm that focuses on early and middle project.
Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 10
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## Green Pine Capital Partners
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 10
- Stages: Series A, Angel, Series B
- Focus: Artificial Intelligence, Manufacturing, Software

Green Pine Capital Partners is a venture capital firm.

## Cowin Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

## ZhenFund
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Seed, Series B
- Focus: Artificial Intelligence, Software, E-Commerce

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

## Gaorong Capital
- Type: VC Fund
- Location: Wangjing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Software, E-Commerce, Information Technology

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.

## K2VC
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Angel, Seed
- Focus: E-Commerce, Health Care, Software

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

## LYFE Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.

## Baidu Ventures
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 8
- Stages: Series A, Seed, Series B
- Focus: Artificial Intelligence, Health Care, Biotechnology

"BV is an independent venture fund established by Baidu in 2017. BV's investors include Baidu as well as other leading financial institutions and businesses. BV currently manages roughly $500M USD across 3 funds and has offices in Beijing and San Francisco. Its mission is to support entrepreneurs and companies who are spearheading the newage of artificial intelligence. These companies are changing the way we work and live—and ultimately how we interact."

## Cowin Venture
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 8
- Stages: Series A, Series B, Angel
- Focus: Biotechnology, Health Care, Medical

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

## Huagai Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 8
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

## Legend Star
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 8
- Stages: Series A, Angel, Seed
- Focus: Health Care, Medical, Biotechnology

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 8
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, E-Commerce

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## EFung Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 8
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

## Lapam Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 8
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Pharmaceutical, Health Care

Lapam Capital is a healthcare-focused venture capital firm.

## Volcanics Venture
- Type: VC Fund
- Location: Changning, Shanghai, China
- Relevant deals: 8
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Software

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

## Source Code Capital
- Type: VC Fund
- Location: Chaoyang, Liaoning, China
- Relevant deals: 8
- Stages: Series B, Series A, Series C
- Focus: Software, E-Commerce, Artificial Intelligence

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

## Lucion
- Type: VC Fund
- Location: Jinan, Shandong, China
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Medical, Manufacturing

Lucion is an influential professional venture capital institute.

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## Shenzhen Capital Group
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 7
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

## Empower Investment
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 7
- Stages: Angel, Series A, Seed
- Focus: Information Technology, Artificial Intelligence, Health Care

Empower Investment was founded in 2012 in Shanghai, China. Their investment covers early-stage ventures, mid-stage growth, and securities in the public market. With headquarters in Shanghai, the company established branch offices in Beijing, Shenzhen, Hangzhou and Chengdu. Empower Investment has invested in over 150 high-tech and high-growthcompanies on a global scale covering regions including China, U.S, India, South Korea, Vietnam and Hong Kong. Their portfolio companies include fast-growing industries such as internet, AI, big data, automation & robotics, financial technology, cultural creativity, advanced materials, and healthcare.The Empower team has extensive experience in both deep technologies and financial services including internet, computer science, electronic engineering, materials science, auditing and investment banking. Some team members were serial entrepreneurs. With candidness and empathy, the team is eager to find and partner with the most visionary, determined and down-to-earth entrepreneurs. It always brings great excitement and pleasure to build a bright future with them.

## BioTrack Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 7
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

BioTrack Capital is a China-based investment firm.

## CASH Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 7
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Manufacturing

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.

## Redhill Capital
- Type: VC Fund
- Location: Guangzhou, Guangdong, China
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Health Care, Medical, Medical Device

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

## Oriza Holdings
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Manufacturing

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

## Oriza Seed Capital (Oriza Yuandian)
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 6
- Stages: Series A, Angel, Seed
- Focus: Health Care, Manufacturing, Biotechnology

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

## SDIC Venture Capital
- Type: VC Fund
- Location: Xicheng, Hebei, China
- Relevant deals: 6
- Stages: Series B, Series A, Series C
- Focus: Manufacturing, Biotechnology, Health Care

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

## SBCVC
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 6
- Stages: Series B, Series A, Series C
- Focus: Health Care, Software, Information Technology

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

## GL Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Software

GL Ventures is a venture capital investment company. The firm typically invests in tech companies specializing in areas like Sports Tech and Online Gaming. Notable portfolio company is Fnatic.

## Bits x Bites
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 6
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Food and Beverage, Food Processing

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

## Sinopharm Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 6
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.

## BVCF
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

BioVeda China Fund (BVCF) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, and Bejing

## F-Prime Capital
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

## Lotus Lake Ventures
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co